News & Updates
Wegovy Pill Sales Disappoint: What It Means for You
Novo Nordisk raised its financial outlook, but investors weren't impressed after oral semaglutide sales came in below expectations. For patients researching GLP-1 medications, this news has real implications for access, pricing, and the future of weight loss treatment options.